LAURA BLAND: Open Payments
NPI 1518606482 · DENTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$320 in 10 payments from 6 companies in 2025. Trend: 2023 $17 · 2024 $203 · 2025 $320
Food & beverage: $320
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $131 |
| Exact Sciences Corporation | 3 | $61 |
| Astellas Pharma US Inc | 2 | $57 |
| Alkermes, Inc. | 1 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: KISUNLA, Veozah, The Cologuard Plus Collection Kit, VIVITROL, Cologuard Collection Kit, ELIQUIS, MOUNJARO.
Industry payments across MD — which companies pay providers there.
